1-3 of 3
Ryan J Meckenzie
Close
Sort by
Journal Articles

OP449, a Novel SET Antagonist, Is Cytotoxic To Leukemia Cells and Enhances Efficacy Of Tyrosine Kinase Inhibitors In Drug-Resistant Myeloid Leukemias

Anupriya Agarwal, Ryan J. Meckenzie, B.S., Raffaella Pippa, Ph.D., Christopher A. Eide, Jessica Oddo, B.S., Jeffrey W. Tyner, Rosalie Sears, Ph.D., Michael P. Vitek, Ph.D., Maria D. Odero, M.D., Ph.D., Dale J. Christensen, Ph.D., Brian J. Druker
Journal: Blood
Blood (2013) 122 (21): 2511.
https://doi.org/10.1182/blood.V122.21.2511.2511
Published: 2013
Journal Articles

Critical Role Of Interleukin Receptor Signaling In Acute Myeloid Leukemia Identified Using An RNAi Functional Screen

Anupriya Agarwal, Ryan J. Meckenzie, B.S., Alyssa Carey, B.A., Monika Davare, Ph.D., Christopher A. Eide, Kevin Watanabe-Smith, B.S., Rita M. Braziel, M.D., Jeffrey W. Tyner, Grover C. Bagby, M.D., Brian J. Druker
Journal: Blood
Blood (2013) 122 (21): 473.
https://doi.org/10.1182/blood.V122.21.473.473
Published: 2013
Journal Articles

p27 Is Mislocalized to the Cytoplasm by BCR-ABL In a Kinase-Independent Manner and Contributes to Leukemogenesis

Anupriya Agarwal, PhD, Ryan J Meckenzie, Thomas O'Hare, PhD, Kavin B Vasudevan, Dorian H LaTocha, Marc M Loriaux, MD, PhD, Eduardo Firpo, James M Roberts, Brian J Druker, MD, Michael W Deininger, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 512.
https://doi.org/10.1182/blood.V116.21.512.512
Published: 2010